Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +0.73% | +4.56% | -32.76% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 362M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
-273
x | P/E ratio 2025 * |
51.2
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | +0.73% | ||
1 week | +2.23% | ||
Current month | +17.02% | ||
1 month | +17.02% | ||
3 months | -5.82% | ||
6 months | +7.84% | ||
Current year | -32.76% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -2.35% | - | |
0.09% | 28 M€ | -1.00% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.75 | +0.73% | 1,035,151 |
24-05-30 | 2.73 | +6.23% | 2,910,560 |
24-05-29 | 2.57 | -3.75% | 392,874 |
24-05-28 | 2.67 | +1.52% | 403,862 |
24-05-24 | 2.63 | -2.23% | 371,773 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.76% | 362M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- ORGO Stock